Preparing for Tomorrow’s Innovations Today: New Trial Results Demonstrate Potential of “SPaL” Regimen to Shorten and Simplify TB Therapy

As the NC-009 trial points to a powerful new TB regimen, the results emphasize why platforms like PeerLINC are essential for translating scientific progress into timely, scalable access worldwide.